Disorder | Gene(s) | Diagnostic tests | Treatment |
Dopa-responsive dystonia, classic | GCH1 | - Levodopa challenge
- CSF pterins and biogenic amines
- Genetic testing
| Levodopa |
Dopa-responsive dystonia, complex | TH, PTPS, SPR | - Levodopa challenge
- CSF HVA, 5-HIAA, and sepiapterin
- Genetic testing
| Levodopa, 5-hydroxytryptophan, or tetrahydrobiopterin |
Dystonia with brain manganese deposition | SLC30A10, SLC9A14 | - Serum manganese and iron
- Peripheral blood smear
- Genetic testing
| Chelation therapy |
Glucose transporter type 1 deficiency | SLC2A1 | - Serum and CSF glucose
- Genetic testing
| Ketogenic diet or triheptanoin |
Rapid-onset dystonia-parkinsonism | ATP1A3 | | Avoid or treat intercurrent illness to prevent encephalopathic crises |
Wilson disease | ATP7B | - Slit lamp examination
- Plasma copper and ceruloplasmin
- 24-hour urine copper
| Zinc or tetrathiomolybdate |
ADCY5-related dyskinesia | ADCY5 | | Caffeine |